Table 1 Patient characteristics at baseline (all patients (n = 43))
From: Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)
Median age (range) | 85 (80–96) |
No. of females (%) | 15 (35) |
No. of males (%) | 28 (65) |
Median no. of comorbidities (IQR) | 3 (2–4) |
Median no. of concomitant medications (IQR) | 6 (3–9) |
Median total OABSS (IQR) | 9 (8–11) |
Median total IPSS (IQR) | 15 (9.5–21) |
Median IPSS QOL score (IQR) | 5 (4–6) |
Median voiding volume (ml) according to UFM (IQR) | 106.35 (56.8–132.8) |
Median maximum flow rate (ml/s) (IQR) | 9.2 (5.4–12.7) |
Median PVR (ml) (IQR) | 15 (6.5–26.8) |
Median VES-13 score (IQR) | 6 (3–8) |
Median MMSE score (IQR) | 27 (25–28) |
Median heart rate (beats/min) (IQR) | 64 (57–73) |
Median QT interval corrected using Fridericia’s formula (ms) (IQR) | 419 (397.25–438) |